Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LEE ENTERPRISES, Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
614
567
544
510
618
795
781
691
611
562
Operating expenses
519
485
468
442
571
745
762
660
611
571
Operating income
104
89.1
85.7
74.7
50.3
56.6
24.9
37.2
4.55
-4.65
Interest expense
64.2
57.6
52.8
47.5
47.7
44.8
41.8
41.5
41.2
40.5
Other non-operating income
-45.8
-48.9
-54.9
-50.9
-47.4
-24.5
-24.1
-40.3
-35.7
-38
Pre-tax income
58.2
40.2
30.8
23.8
2.84
32
0.8
-3.08
-31.2
-42.6
Income tax
22.2
11.6
-16.2
7.93
2.97
7.26
0.7
-0.35
-7.61
-6.9
Net income to minority interests
1.06
1.12
1.28
1.64
1.85
2.05
2.11
2.53
2.27
1.85
Net income
35
27.5
45.8
14.3
-1.98
22.7
-2.02
-5.27
-25.8
-37.6
EBITDA
147
130
117
104
86.4
99.4
61.4
67.8
32.2
14.2
EPS, basic
4.22
3.26
5.37
1.64
-0.35
3.98
-0.35
-0.90
-4.35
-6.20
EPS, diluted
4.09
3.19
5.24
1.60
-0.35
3.90
-0.35
-0.90
-4.35
-6.20
Shares, basic (weighted)
8.33
8.45
8.56
8.73
5.66
5.72
5.78
5.87
5.94
6.07
Shares, diluted (weighted)
8.49
8.67
8.76
8.94
5.69
5.83
5.78
5.87
5.94
6.07
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
17
10.6
5.38
8.65
33.7
26.1
16.2
14.5
9.6
9.99
Receivables
43.7
42.5
52.6
65.1
69.5
69.1
60.6
54.6
Inventory
4.25
3.62
5.68
3.77
7.53
6.3
8.27
7.5
5.64
4.7
Other current assets
4.68
4.13
4.57
5.35
14.9
11.3
15.2
15.4
21.9
20.1
Total current assets
77.3
67.8
59.3
60.3
109
109
109
107
97.8
89.4
Property, plant and equipment
129
114
92.3
82
106
83.3
73.7
61.2
44.4
35.6
Lease right-of-use assets
0
70.9
65.7
47.5
40.8
34.9
25.2
Goodwill
244
246
246
250
328
330
330
330
328
324
Intangible assets
158
136
120
107
183
157
121
95
70.1
51.9
Long-term investments
39.2
39.1
40.2
39.4
33.9
32.7
33.3
33.4
34
Other non-current assets
1.69
1.57
1.42
1.39
13.7
13.6
9.9
12.7
12.1
9.36
Total assets
663
621
575
555
864
844
744
712
649
602
Accounts payable
18.1
17
12.7
16.8
17.2
20.4
28.6
36.3
36.3
41.7
Accrued liabilities
23.9
22.6
19.6
17.7
44.3
45.1
44.7
29.4
39.2
37.9
Deferred revenue
28.4
26.9
23.9
21.7
60.3
61.4
49.9
40.8
31.8
26.5
Short-term debt
25.1
30.2
7.03
2.95
13.7
6.11
0
0
0
Total current liabilities
99
98.2
65.3
61
144
142
131
114
115
113
Long-term debt
566
496
461
429
525
477
463
456
446
455
Lease liabilities
0
62.4
57.7
46
36.6
29.8
18.8
Other non-current liabilities
16.4
10
10.6
13.5
14.3
28.1
25.9
24.9
25.5
23.8
Total liabilities
790
712
612
592
907
800
727
688
657
643
Total debt
566
496
461
429
525
483
463
456
446
455
Paid-in capital
250
252
254
255
257
258
260
261
262
264
Retained earnings
-356
-329
-280
-265
-282
-259
-261
-266
-292
-330
Other comprehensive income
-22.8
-16.1
-11.7
-29.1
-20.1
42.2
16.7
26.8
19.9
22.8
Shareholders' equity
-128
-92.2
-37.4
-38.5
-45
41.1
15
21.2
-9.89
-43.3
Minority interests
0.94
1.02
1.09
1.65
1.93
2.13
2.23
2.47
2.56
2.35
Total equity
-128
-91.2
-36.3
-36.8
-43.1
43.2
17.2
23.7
-7.33
-41
Total liabilities and equity
663
621
575
555
864
844
744
712
649
602
Shares outstanding
8.73
8.88
8.94
6.06
6.19
6.19
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
36
28.6
47
15.9
-0.13
24.8
0.1
-2.73
-23.6
-35.7
Depreciation and amortization
43.4
41.3
31.8
29.3
36.1
42.8
36.5
30.6
27.6
18.8
Stock-based compensation
2.31
2.09
1.86
1.64
1.29
0.85
1.34
1.81
1.75
1.76
Deferred income tax
20.7
10.4
-17.4
-2
-4.69
6.04
-4.38
-4.54
-10.5
-6.91
Change in receivables
6.93
2.85
4.42
1.7
-6.74
-5.49
-9.23
Change in payables
-6.39
-8.59
-3.68
-8.34
4.73
-14.6
Cash from operations
79.2
72.3
59.3
57.7
49.9
50.1
2.85
-3.18
1.12
-5.54
Capital expenditures
-7.09
-4.08
-6.03
-5.9
-8.1
-7.48
-7.54
-5.11
-9.21
-1.54
Acquisitions
0
-7.45
0
-6.54
-131
0
0
Cash from investing
34.5
-9.46
-0.07
-10.9
-118
-2.28
6.91
8.64
3.73
7.71
Debt issued
5
5
10
0.6
576
0
0
Debt repaid
-112
-73.8
-73.5
-41.8
-444
0
0
Cash from financing
-108
-69.2
-64.5
-43.5
93.4
-55.4
-19.7
-7.09
-9.8
-1.78
Net change in cash
5.85
-6.36
-5.24
3.27
25.1
-7.62
-9.93
-1.64
-4.95
0.39
Free cash flow
72.1
68.2
53.3
51.8
41.8
42.6
-4.68
-8.29
-8.09
-7.08
Interest paid
65.4
58.8
52.2
47.6
49.5
45.2
41.8
41.5
41.2
40.5
Income taxes paid
0.27
1.21
0.46
8.44
0.45
7.6
5.31
3.72
7.37
2.91
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $6.79 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
4.0%
Operating income / revenue.
EBITDA margin
6.8%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1.4%
Pre-tax income / revenue.
Net margin
-1.8%
Net income / revenue.
FCF margin
-0.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.0%
Cash from operations / revenue.
Return on assets (ROA)
-1.5%
Net income / average total assets.
Return on invested capital (ROIC)
4.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
0.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.1%
Capital expenditures / revenue.
D&A / revenue
2.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-8.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-10.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-1.9%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y
-202.3%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-55.9%
EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y
-38.6%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y
-30.3%
Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-596.1%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-7.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-6.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-7.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
2.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
1.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.17x
Current assets / current liabilities.
Quick ratio
1.01x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.57x
(Cash + short-term investments) / current liabilities.
Debt / assets
72.8%
Total debt / total assets.
Liabilities / assets
100.0%
Total liabilities / total assets.
Net debt
$395.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
11.2x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$23.20
Revenue / diluted weighted shares.
FCF per share
-$0.03
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.01
Cash from operations / diluted weighted shares.
Book value per share
-$0.10
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.29x
Market cap / revenue.
EV/Sales
1.06x
Enterprise value / revenue.
EV/EBIT
26.1x
Enterprise value / operating income, when both are positive.
EV/EBITDA
15.5x
Enterprise value / EBITDA, when both are positive.
FCF yield
-0.4%
Free cash flow / market cap.
Earnings yield
-6.3%
Net income / market cap (the inverse of P/E).
What was LEE ENTERPRISES, Inc's revenue in fiscal 2025?
LEE ENTERPRISES, Inc reported revenue of $562.3M for fiscal 2025, 8% lower than the year before.
Was LEE ENTERPRISES, Inc profitable in fiscal 2025?
No. It reported a net loss of $37.6M.
How much free cash flow did LEE ENTERPRISES, Inc generate in fiscal 2025?
Cash from operations of $5.5M minus capital expenditures of $1.5M left free cash flow of -$7.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.